• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组组织型纤溶酶原激活剂在栓塞性中风中的评估。

Evaluation of recombinant tissue plasminogen activator in embolic stroke.

作者信息

Chehrazi B B, Seibert J A, Kissel P, Hein L, Brock J M

机构信息

Department of Neurological Surgery, University of California, Davis.

出版信息

Neurosurgery. 1989 Mar;24(3):355-60. doi: 10.1227/00006123-198903000-00008.

DOI:10.1227/00006123-198903000-00008
PMID:2494563
Abstract

In an effort to determine the value of tissue-type plasminogen activator (TPA) in the treatment of embolic stroke, 17 rabbits were subjected to a model of embolic stroke in which 2-hour-old, tin-impregnated, autologous clots were embolized to the bifurcation of the internal carotid artery at the circle of Willis via retrograde injection into the cannulated external carotid artery. High-resolution digital subtraction radiography was used to localize clots intracranially at the carotid bifurcation. Circulation through the internal carotid artery and intracranial vessels was monitored with serial digital subtraction angiography before and after embolization and during treatment. Disappearance of the tin marker on the digital subtraction radiograph indicated dissolution of clot and was associated with reestablishment of circulation on the digital subtraction angiogram. Experimental animals were treated with human-specific recombinant TPA 30 minutes, 2 hours, or 4 hours after clot embolization. TPA was administered as an intravenous bolus of 0.5 mg/kg followed by an infusion of 1 mg/kg/h for 2 hours. Digital subtraction angiograms were performed every 30 minutes. All clots dissolved, and cerebral circulation was reestablished within 120 minutes of treatment. In control animals treated with saline, embolized clots were stable, and the internal carotid artery remained occluded. At the completion of each study, the animal was perfused with freshly prepared, buffered 2,3,5-triphenyltetrazolium chloride (TTC) for demarcation of cerebral infarction. Control animals demonstrated infarction of 50 +/- 3.6% of the ipsilateral cerebral hemisphere, with an infarct weight of 2.1 +/- 0.2 g.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了确定组织型纤溶酶原激活剂(TPA)在治疗栓塞性中风中的价值,对17只兔子进行了栓塞性中风模型实验。通过逆行注入插管的颈外动脉,将2小时龄、含锡的自体血栓栓塞到 Willis 环处的颈内动脉分叉处。采用高分辨率数字减影血管造影术在颅内颈动脉分叉处定位血栓。在栓塞前后及治疗期间,通过系列数字减影血管造影术监测颈内动脉和颅内血管的血流情况。数字减影放射照片上锡标记的消失表明血栓溶解,并与数字减影血管造影上血流的重新建立相关。实验动物在血栓栓塞后30分钟、2小时或4小时接受人特异性重组TPA治疗。TPA以0.5mg/kg静脉推注给药,随后以1mg/kg/h的速度输注2小时。每30分钟进行一次数字减影血管造影。所有血栓均溶解,治疗后120分钟内脑循环得以重建。在用生理盐水治疗的对照动物中,栓塞的血栓保持稳定,颈内动脉仍处于闭塞状态。在每项研究结束时,用新鲜配制的缓冲2,3,5-三苯基氯化四氮唑(TTC)灌注动物以划定脑梗死范围。对照动物同侧脑半球梗死面积为50±3.6%,梗死重量为2.1±0.2g。(摘要截断于250字)

相似文献

1
Evaluation of recombinant tissue plasminogen activator in embolic stroke.重组组织型纤溶酶原激活剂在栓塞性中风中的评估。
Neurosurgery. 1989 Mar;24(3):355-60. doi: 10.1227/00006123-198903000-00008.
2
Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator.
J Neurosurg. 1987 Sep;67(3):399-405. doi: 10.3171/jns.1987.67.3.0399.
3
Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.自旋捕捉剂二钠-[(叔丁基亚氨基)甲基]苯-1,3-二磺酸盐N-氧化物(通用名NXY-059)在兔小血栓栓塞性中风模型中的神经保护作用:与溶栓组织纤溶酶原激活剂的联合研究
Stroke. 2002 May;33(5):1411-5. doi: 10.1161/01.str.0000015346.00054.8b.
4
Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries.重组组织型纤溶酶原激活剂诱导的溶栓在中枢神经系统和体动脉中的差异效应。
Neurosurgery. 1991 Mar;28(3):364-9. doi: 10.1097/00006123-199103000-00005.
5
A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.动脉内与静脉内注射组织型纤溶酶原激活剂对兔脑循环中自体动脉栓子作用的比较。
Stroke. 1994 Mar;25(3):651-5; discussion 656. doi: 10.1161/01.str.25.3.651.
6
Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.重组人组织型纤溶酶原激活剂治疗急性血栓栓塞性卒中
J Neurosurg. 1987 Sep;67(3):394-8. doi: 10.3171/jns.1987.67.3.0394.
7
Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.依布硒啉,一种有机硒抗氧化剂,对兔栓塞性中风具有神经保护作用:与低剂量组织纤溶酶原激活剂协同作用。
Stroke. 2003 Aug;34(8):2013-8. doi: 10.1161/01.STR.0000081223.74129.04. Epub 2003 Jul 10.
8
Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].动脉内注射组织型纤溶酶原激活剂和尿激酶对兔脑循环中自体动脉栓子的影响[校正后]
Stroke. 1990 Nov;21(11):1594-9. doi: 10.1161/01.str.21.11.1594.
9
Combination tissue plasminogen activator and ticlopidine therapy in a rabbit model of acute thromboembolic stroke.组织型纤溶酶原激活剂与噻氯匹定联合治疗兔急性血栓栓塞性中风模型
Neurol Res. 1996 Feb;18(1):45-8. doi: 10.1080/01616412.1996.11740376.
10
Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration.兔体内组织型纤溶酶原激活剂脑血管溶栓作用取决于给药速率和途径。
Stroke. 1992 Mar;23(3):388-93. doi: 10.1161/01.str.23.3.388.

引用本文的文献

1
Occurrence and timing of withdrawal of life-sustaining measures in traumatic brain injury patients: a CENTER-TBI study.创伤性脑损伤患者生命支持措施的撤停时间和发生情况:CENTER-TBI 研究。
Intensive Care Med. 2021 Oct;47(10):1115-1129. doi: 10.1007/s00134-021-06484-1. Epub 2021 Aug 5.
2
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?目前的人类中风动物模型的基本假设是否正确:从 STAIRs 到高障碍?
Transl Stroke Res. 2011 Jun;2(2):138-43. doi: 10.1007/s12975-011-0067-3. Epub 2011 Feb 12.
3
Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development.
应用兔栓塞性卒中模型的转化卒中研究:新型治疗方法开发的相关分析假设。
Transl Stroke Res. 2010 Jun;1(2):96-107. doi: 10.1007/s12975-010-0018-4. Epub 2010 Apr 2.
4
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?一项关于依达拉奉急性缺血性脑卒中疗效试验的关键性评估:依达拉奉是否为一种有效的神经保护治疗方法?
Expert Opin Pharmacother. 2010 Jul;11(10):1753-63. doi: 10.1517/14656566.2010.493558.